Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : ADVR:THE NEW COMPANY...WITH A NEW LIFE...AND A NEW MISSION -- Ignore unavailable to you. Want to Upgrade?

To: OLD JAKE JUSTUS who wrote (382)	6/11/1998 6:33:00 PM
From: DAN LITTLE	Read Replies (2) \| Respond to of 4891

In one of the last three SEC filings, I forget which one I will look later and report back, it reported that ADVR had NO Reticulose in stock and was capable of making 1500 ampules a week (I believe 2ml each). If each individual is using 2ml a day for the first two weeks (28ml) and another 28ml for the next 60 days = 58ml for each person. Thats just to get started. According to the the SEC filings there are some six hundred people involved with the study. Of course some of these are HPV and I don't know how much R is used dailey for that. But you can see that even if these numbers are within 50% we are a little short. Maybe I am looking at it wrong but these are the only numbers I can find and I have no reason to believe they are wrong. They come from the ADVR SEC reports. Of course that still leads us back to the same problem. We are not very well informed so it could be anything. Anyone else care to work the numbers? I will refine them this weekend. Dan PS We only have SEC reports through March. Several things could have changed. Same applies with the possibility of a new manufacturing plant. Whats happened the last two and a half months?